ertapenem has been researched along with Infections, Respiratory in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Di Maggio, T; Docquier, JD; Landini, G; Pallecchi, L; Rossolini, GM; Sergio, F | 1 |
| Debbia, EA; Gualco, L; Marchese, A; Schito, AM; Schito, GC | 1 |
| Alhambra, A; Alós, JI; Gómez-Garcés, JL; Hernáiz, C | 1 |
| Baek, JY; Heo, ST; Ko, KS; Kwon, KT; Lee, JY; Lee, MY; Lee, NY; Oh, WS; Park, S; Peck, KR; Ryu, SY; Song, JH | 1 |
| Joseph, J; Rodvold, KA | 1 |
| Friedland, I; Jiang, Q; Legua, P; Lema, J; Moll, J; Woods, G | 1 |
1 review(s) available for ertapenem and Infections, Respiratory
| Article | Year |
|---|---|
The role of carbapenems in the treatment of severe nosocomial respiratory tract infections.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cross Infection; Doripenem; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Ertapenem; Humans; Imipenem; Meropenem; Patient Selection; Pneumonia, Bacterial; Respiratory Tract Infections; Severity of Illness Index; Thienamycins; Treatment Outcome | 2008 |
1 trial(s) available for ertapenem and Infections, Respiratory
| Article | Year |
|---|---|
Safety and local tolerability of intramuscularly administered ertapenem diluted in lidocaine: a prospective, randomized, double-blind study versus intramuscular ceftriaxone.
Topics: Aged; Anesthetics, Local; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Cephalosporins; Double-Blind Method; Ertapenem; Female; Humans; Injections, Intramuscular; Lactams; Lidocaine; Male; Middle Aged; Prospective Studies; Respiratory Tract Infections; Skin Diseases, Infectious | 2002 |
4 other study(ies) available for ertapenem and Infections, Respiratory
| Article | Year |
|---|---|
Effect of High N-Acetylcysteine Concentrations on Antibiotic Activity against a Large Collection of Respiratory Pathogens.
Topics: Acetylcysteine; Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Drug Combinations; Drug Interactions; Enterobacter cloacae; Ertapenem; Escherichia coli; Humans; Imipenem; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Penicillins; Pseudomonas aeruginosa; Respiratory Tract Infections; Staphylococcus aureus; Streptococcus pneumoniae; Streptococcus pyogenes; Thienamycins | 2016 |
In vitro activity of ertapenem against selected respiratory pathogens.
Topics: Bacteria; beta-Lactams; Ertapenem; Humans; Lactams; Microbial Sensitivity Tests; Moraxella catarrhalis; Respiratory Tract Infections; Staphylococcus aureus; Streptococcus pneumoniae; Streptococcus pyogenes | 2004 |
[Activity of ertapenem and 19 other antimicrobial agents against beta-lactam-resistant Streptococcus pneumoniae and Haemophilus influenzae respiratory tract isolates].
Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; beta-Lactam Resistance; beta-Lactams; Child; Drug Resistance, Multiple, Bacterial; Ertapenem; Haemophilus influenzae; Humans; Lactams; Microbial Sensitivity Tests; Penicillin G; Penicillin Resistance; Respiratory Tract Infections; Spain; Streptococcus pneumoniae | 2005 |
In vitro activities of ertapenem against drug-resistant Streptococcus pneumoniae and other respiratory pathogens from 12 Asian countries.
Topics: Anti-Bacterial Agents; Asia; Bacterial Infections; beta-Lactamases; beta-Lactams; Drug Resistance, Multiple, Bacterial; Ertapenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Pneumococcal Infections; Respiratory Tract Infections; Sentinel Surveillance; Streptococcus pneumoniae | 2006 |